MediPal Holdings Corporation
Research MediPal Holdings Corporation (7459.T) on Bullrun: market cap JPY 639.68B, P/E 13.9, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7459.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyJPY
- Market capJPY 639.68B
- P/E13.9
- Dividend yield2.5%
- Financial periodFY2026
- RevenueJPY 3.82T
- Revenue growth4.0%
- Net incomeJPY 42.53B
- Free cash flowJPY 36.87B
- Gross margin6.8%
Valuation Snapshot
latest market cap is JPY 639.68B; P/E is 13.9; dividend yield is 2.5%.
Peer valuation comparison
Latest P/E is 13.87x versus a Healthcare sector median of 21.69x (36.1% below).
Latest dividend yield is 2.47% versus a Healthcare sector median of 2.41% (2.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 3.82T | JPY 42.53B | JPY 36.87B | 6.8% | 206.67 | JPY 289.07B | n/a | JPY 652.17B |
| FY2025 | JPY 3.67T | JPY 40.28B | JPY 48.13B | 7.0% | 193.2 | JPY 261.41B | n/a | JPY 619.56B |
| FY2024 | JPY 3.56T | JPY 41.47B | JPY 42.45B | 6.9% | 195.83 | JPY 230.15B | n/a | JPY 600.35B |
| FY2023 | JPY 3.36T | JPY 38.81B | JPY 2.64B | 6.7% | 179.12 | JPY 195.03B | JPY 0 | JPY 561.36B |
| FY2022 | JPY 3.29T | JPY 29.42B | JPY 42.34B | 6.6% | 131.41 | JPY 243.15B | JPY 30.08B | JPY 530.30B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 639.68B | 13.9 | 2.8% | 88 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 88 JPY, yield 2.5%.
| Year | Dividends/share |
|---|---|
| FY2026 | 78 JPY |
| FY2025 | 64 JPY |
| FY2024 | 60 JPY |
| FY2023 | 53 JPY |
| FY2022 | 0.25 JPY |
About MediPal Holdings Corporation
MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MediPal Holdings Corporation's market cap?
MediPal Holdings Corporation's market capitalization is JPY 639.68B.
What is MediPal Holdings Corporation's P/E ratio?
MediPal Holdings Corporation's price-to-earnings (P/E) ratio is 13.9.
Does MediPal Holdings Corporation pay a dividend?
MediPal Holdings Corporation has a dividend yield of 2.5%.
What does MediPal Holdings Corporation do?
MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database.